Ion News and Research

RSS

Common gene variations found to influence risk factor for sudden cardiac death

A new study has identified several common genetic variants related to a risk factor for sudden cardiac death.

23 Mar 2009

Tiny genetic change keeps nicotine from binding to muscle cells

A tiny genetic mutation is the key to understanding why nicotine--which binds to brain receptors with such addictive potency--is virtually powerless in muscle cells that are studded with the same type of receptor.

23 Mar 2009

Phylonix granted broad U.S. patent for assessing cardiac functions in Zebrafish

Phylonix Pharmaceuticals announced, at the Society of Toxicology Annual Meeting in Baltimore, that the U.S. Patent and Trademark Office has issued the company a broad patent for assessing the toxicity of pharmaceutical test agents on cardiovascular functions in zebrafish.

15 Mar 2009

First high-resolution images of the earliest stages of bone formation

Researchers at Eindhoven University of Technology (TU/e) have for the first time made high-resolution images of the earliest stages of bone formation.

12 Mar 2009

Space-grown bacteria help explain Salmonella illness

Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.

11 Mar 2009

New insights on heart's 'fight or flight' response to stress

Even for those without a heart condition, it's a peculiar feeling when your heart "races" in response to stress.

10 Mar 2009

Immune reaction to metals in joint replacement devices leads to early failure

Researchers at Rush University Medical Center have identified a key immunological defense reaction to the metals in joint replacement devices, leading to loosening of the components and early failure.

4 Mar 2009

New mechanistic explanation of how the brain interprets stress signals

Chronic stress takes a physical and emotional toll on our bodies and scientists are working on piecing together a medical puzzle to understand how we respond to stress at the cellular level in the brain.

2 Mar 2009

ESA Biosciences to launch Corona CAD at Pittcon 2009

ESA Biosciences, Inc., a Magellan Biosciences company and leader in novel HPLC systems that improve results for pharmaceutical development and QA/QC, life science, and analytical-chemistry customers worldwide, will launch a new, ultra-high-performance version of its award-winning Corona CAD at Pittcon 2009.

2 Mar 2009

Experimental drug fampridine improves mobility for some MS patients

In MS, the body's immune system attacks myelin, a fatty tissue that wraps and insultates nerve fibers, disrupting the transmission of signals in the central nervous system.

1 Mar 2009

Compounds that trigger beta cell replication identified

Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput screening techniques.

25 Feb 2009

Oxford Nanopore announces publication of DNA analysis paper

Oxford Nanopore Technologies ("Oxford Nanopore") today announced the publication of new research in Nature Nanotechnology, demonstrating accurate and continuous identification of DNA bases using nanopores.

From Oxford Nanopore Technologies 23 Feb 2009

Researchers cast doubt on role of free radicals in aging

For more than 40 years, the prevailing explanation of why we get old has been tied to what is called oxidative stress.

18 Feb 2009

X-ray eyes bring us closer to early diagnosis of Parkinson's disease

It is estimated that 4 million people world-wide are suffering from Parkinson's, a complex disease that varies greatly among affected individuals.

17 Feb 2009

Experimental antiarrhythmic drug dronedarone reduces death rate in patients with atrial fibrillation

Results from the ATHENA trial, reported in the 12th February issue of the New England Journal of Medicine , suggest that the (as yet unlicensed) antiarrhythmic drug dronedarone can reduce the incidence of cardiovascular-related hospitalisation or death in patients with atrial fibrillation.

16 Feb 2009